We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

China's Anti-Doping Agency Prepares for Olympic Games

By Labmedica staff writers
Posted on 05 Jun 2008
The China Anti-Doping Agency (Beijing, China) will examine more than 4,500 samples from athletes for banned drugs during the 2008 Olympic Games.

Three leadership delegations so far from the Chinese agency have been hosted by Agilent Technologies Inc. The meetings include technical training on anti-doping instruments and methods developed by Agilent (Santa Clara, CA, USA), a primary supplier of technology to China's Anti-Doping Agency since 1988.

The agency has equipped its Beijing lab with Agilent liquid chromatography (LC), gas chromatography (GC), and mass spectrometry (MS) instruments to confirm the chemical identity of suspected banned substances found in testing samples. Agilent is providing 18 LC/MS units and 19 GC/MS units for drug testing at the Games.

"China has quickly become a world model for anti-doping efforts,” said Du Lijun, director of China's Anti-Doping Agency. "Agilent's liquid chromatography and mass spectrometry instrumentation will help make China's Anti-Doping Agency testing in the 2008 Olympic Games the most technologically advanced yet.”


Related Links:
China Anti-Doping Agency
Agilent

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic CLIA Analyzer
Shine i6000
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest Clinical Chem. News

Automated NfL Assay Supports Monitoring of Neurological Disorders
05 Jun 2008  |   Clinical Chem.

Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
05 Jun 2008  |   Clinical Chem.

New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
05 Jun 2008  |   Clinical Chem.



INTEGRA BIOSCIENCES AG